Back to 
Verition Fund Management LLC
Verition Fund Management LLC
KNSA
Showing 0 of 2 quarters
Position history for Verition Fund Management LLC's holdings in KINIKSA PHARMACEUTICALS-A
No. Verition Fund Management exited its KNSA (Kiniksa Pharmaceuticals) position in Q2 2020. Its Q1 2020 13F listed 19,700 shares worth $305,000. Verition Fund Management first reported KNSA in Q1 2020 and held it in 1 quarterly 13F filing.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.